98%
921
2 minutes
20
Lung nodule progression assessment from medical imaging is a critical biomarker for assessing the course of the disease or the patient's response to therapy. CT images are routinely used to identify the location and size and rack the progression of lung nodules. However, nodule segmentation is challenging and prone to error, due to the irregular nodule boundaries, therefore introducing error in the lung nodule quantification process. Here, we describe the development and evaluation of a feature-based affine image registration framework that enables us to register two time point thoracic CT images as a means to account for the back-ground lung tissue deformation, then use digital subtraction images to assess tumor progression/regression. We have demonstrated this method on twelve de-identified patient datasets and showed that the proposed method yielded a better than 1.5mm registration accuracy vis-à-vis the widely accepted non-rigid image registration techniques. To demonstrate the potential clinical value of our described technique, we conducted a study in which our collaborating clinician was asked to provide an assessment of nodule progression/regression using the digital subtraction images post-registration. This assessment was consistent, yet provided more confidence, than the traditional lung nodule tracking based on visual analysis of the CT images.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375750 | PMC |
http://dx.doi.org/10.1007/978-3-030-32040-9_26 | DOI Listing |
Eur J Case Rep Intern Med
August 2025
Medical Subspecialities Department, Rheumatology Section, King Fahad Medical City, Riyadh, Saudi Arabia.
Unlabelled: Concurrent presentation of pulmonary nocardiosis and granulomatosis with polyangiitis (GPA) is exceptionally rare and diagnostically challenging, given the overlapping clinical and radiological features. We report a 54-year-old female with fever, cough, weight loss, and arthralgia. Chest imaging showed multiple pulmonary nodules; serology revealed positive anti-neutrophil cytoplasmic antibodies -proteinase 3, and lung biopsy demonstrated necrotizing granulomatous inflammation with Nocardia species.
View Article and Find Full Text PDFJ Surg Case Rep
September 2025
Department of Dermatology and Sexually Transmitted Disease, Tishreen University Hospital, Lattakia 041, Syria.
Hepatoid adenocarcinoma of the lung (HAL) is a rare and aggressive subtype of pulmonary adenocarcinoma, with cutaneous metastasis being an uncommon clinical manifestation. A 49-year-old male presented with a painful, nodular skin lesion on the upper back. Histopathological examination confirmed it as a cutaneous metastasis of HAL.
View Article and Find Full Text PDFCureus
August 2025
Acute Medicine, Southend University Hospital, Mid and South Essex NHS Foundation Trust, Southend-on-Sea, GBR.
Adenocarcinoma of the lung is the most common type of lung cancer and is classified as one of the non-small cell lung cancers. It typically arises in the peripheral regions of the lungs, affecting the dense glandular tissues. Most patients diagnosed with pulmonary adenocarcinoma are current or former smokers and present with nonspecific respiratory symptoms such as a persistent cough and shortness of breath.
View Article and Find Full Text PDFPLoS One
September 2025
Department of Radiology, the Third Affiliated Hospital of Kunming Medical University, Yunnan, Kunming, China.
Purpose: Bronchiolar adenoma (BA) is a rare benign pulmonary neoplasm originating from the bronchial mucosal epithelium and mimics lung adenocarcinoma (LAC) both radiographically and microscopically. This study aimed to develop a nomogram for distinguishing BA from LAC by integrating clinical characteristics and artificial intelligence (AI)-derived histogram parameters across two medical centers.
Methods: This retrospective study included 215 patients with diagnoses confirmed by postoperative pathology from two medical centers.
Radiol Med
September 2025
Breast Imaging Division, Radiology Department, IEO European Institute of Oncology IRCCS, 20141, Milan, Italy.
Metastatic involvement (MB) of the breast from extramammary malignancies is rare, with an incidence of 0.09-1.3% of all breast malignancies.
View Article and Find Full Text PDF